pISSN 2287-2728
eISSN 2287-285X
http://dx.doi.org/10.3350/cmh.2016.22.1.18
Clinical and Molecular Hepatology 2016;22:18-75Review
Corresponding author : KASL (Committee chair: Kwan Sik Lee)
Room A1210 MapoTrapalace, 53 Mapo-daero, Mapo-gu, Seoul 04158, Korea
Tel: +82-2-703-0051, Fax: +82-2-703-0071
E-mail: kasl@kams.or.kr
* Clinical Practice Guidelines Committee of KASL for the
Management of Chronic Hepatitis B
Kwan Sik Lee (Committee Chair, Yonsei University College of Medicine), Si Hyun
Bae (Catholic University of Korea), Won Hyeok Choe (Konkuk University College
of Medicine), Moon Seok Choi (Sungkyunkwan University School of Medicine),
Woo Jin Chung (Keimyung University School of Medicine), Chang Wook Kim
(Catholic University of Korea), Hyung Joon Kim (Chung-Ang University College
of Medicine), Ja Kyung Kim (Yonsei University College of Medicine), Ji Hoon Kim
(Korea University College of Medicine), Suk Bae Kim (Dankook University Medical
College), Yoon Jun Kim (Seoul National University College of Medicine), Jae Sung
Ko (Seoul National University College of Medicine), Byung Seok Lee (Chungnam
National University College of Medicine), Jung Il Lee (Yonsei University College
of Medicine), Young-Suk Lim (University of Ulsan College of Medicine), Won
Young Tak (Kyungpook National University School of Medicine), Jong Eun Yeon
(Korea University College of Medicine), Ki Tae Yoon (Pusan National University
School of Medicine).
Received : Feb. 18, 2016 / Accepted : Feb. 22, 2016
PREAMBLE
Aims
The clinical practice guidelines for the management of chronic
hepatitis B (CHB) were first presented in 2004 by the Korean As-
sociation for the Study of the Liver (KASL), and were revised in
2007 and 2011. The American Association for the Study of Liver
Diseases (AASLD) published their guidelines in 2015, the Europe-
an Association for the Study of the Liver (EASL) in 2012, the Asian
Pacific Association for the Study of the Liver (APASL) in 2015 and
the Wor
【肝病】2016+KASL临床实践指南:慢性乙型肝炎的管理.pdf